Louisiana State Employees Retirement System Has $7.95 Million Stake in Axon Enterprise, Inc $AXON

Louisiana State Employees Retirement System boosted its position in Axon Enterprise, Inc (NASDAQ:AXON) by 1.1% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 9,600 shares of the biotechnology company’s stock after purchasing an additional 100 shares during the period. Louisiana State Employees Retirement System’s holdings in Axon Enterprise were worth $7,948,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the business. LaSalle St. Investment Advisors LLC raised its position in shares of Axon Enterprise by 2.1% in the 1st quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company’s stock worth $408,000 after acquiring an additional 16 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in Axon Enterprise by 5.0% during the first quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company’s stock worth $203,000 after purchasing an additional 18 shares during the period. Pinion Investment Advisors LLC grew its stake in Axon Enterprise by 3.0% during the first quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company’s stock worth $341,000 after purchasing an additional 19 shares during the period. Kentucky Retirement Systems boosted its holdings in shares of Axon Enterprise by 0.4% during the 1st quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company’s stock worth $2,605,000 after buying an additional 19 shares in the last quarter. Finally, WCM Investment Management LLC boosted its holdings in shares of Axon Enterprise by 0.8% during the 1st quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company’s stock worth $1,306,000 after buying an additional 19 shares in the last quarter. 79.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on AXON. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. UBS Group reiterated a “neutral” rating and issued a $840.00 price target (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Axon Enterprise in a report on Saturday, September 27th. Needham & Company LLC reaffirmed a “buy” rating and set a $870.00 target price on shares of Axon Enterprise in a research report on Wednesday, September 24th. Finally, Piper Sandler initiated coverage on Axon Enterprise in a research report on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 target price on the stock. Fourteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $841.64.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $714.60 on Wednesday. The company has a market cap of $56.10 billion, a PE ratio of 176.44, a price-to-earnings-growth ratio of 28.02 and a beta of 1.41. Axon Enterprise, Inc has a 52 week low of $420.49 and a 52 week high of $885.91. The business has a 50 day moving average price of $757.21 and a 200-day moving average price of $710.53. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. During the same quarter in the prior year, the company posted $1.20 earnings per share. Axon Enterprise’s revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. Equities analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the transaction, the chief executive officer directly owned 3,053,982 shares of the company’s stock, valued at $2,538,744,696.78. This trade represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jeffrey C. Kunins sold 7,891 shares of the firm’s stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the transaction, the insider directly owned 144,538 shares in the company, valued at $108,417,953.80. The trade was a 5.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 49,932 shares of company stock worth $37,978,216. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.